More patients in England and Wales with chronic DME could benefit from low-dose corticosteroid intravitreal implant that lasts up to three years
PR Newswire
ATLANTA, June 11, 2018
PR Newswire
ATLANTA, June 11, 2018
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey